Dimensional Fund Advisors’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Other funds holding ARCT
AIM
NAMA
Dimensional Fund Advisors's ARCT Position: Q2 2026 in Review
Dimensional Fund Advisors reduced its Arcturus Therapeutics (ARCT) stake by 23% in Q2 2026, selling an estimated $528K and leaving 221,322 shares worth $1.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2799.
Dimensional Fund Advisors first reported a position in ARCT in Q4 2021 and has held it in 18 quarters since. The position peaked at $37.3M in Q1 2024. 135 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.
- Dimensional Fund Advisors held 221,322 shares of Arcturus Therapeutics worth $1.49M as of Q2 2026.
- Dimensional Fund Advisors sold 67,033 Arcturus Therapeutics shares in Q2 2026, an estimated $528K.
- Arcturus Therapeutics made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #2799 holding.
- Dimensional Fund Advisors first reported a position in Arcturus Therapeutics in Q4 2021 and has held it in 18 quarters since.
- Dimensional Fund Advisors's Arcturus Therapeutics position peaked at $37.3M in Q1 2024.
- 135 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.
Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.